XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 80 filers reported holding XENON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $44,000 | -90.8% | 2,365 | -91.1% | 0.00% | -100.0% |
| Q1 2021 | $476,000 | -60.1% | 26,653 | -65.5% | 0.00% | -60.0% |
| Q4 2020 | $1,192,000 | +30.3% | 77,358 | -6.5% | 0.01% | +25.0% |
| Q3 2020 | $915,000 | +20.1% | 82,717 | +35.8% | 0.00% | +33.3% |
| Q2 2020 | $762,000 | +1090.6% | 60,928 | +971.9% | 0.00% | – |
| Q1 2020 | $64,000 | -25.6% | 5,684 | -45.7% | 0.00% | – |
| Q3 2015 | $86,000 | -66.3% | 10,474 | -52.7% | 0.00% | -100.0% |
| Q2 2015 | $255,000 | +292.3% | 22,126 | +468.9% | 0.00% | – |
| Q1 2015 | $65,000 | -8.5% | 3,889 | +8.6% | 0.00% | – |
| Q4 2014 | $71,000 | – | 3,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |